Data as of Jul 30
| +2.49 / +1.12%|
The 3 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 300.00, with a high estimate of 325.00 and a low estimate of 292.00. The median estimate represents a +33.64% increase from the last price of 224.49.
The current consensus among 4 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.